Investors & Media

The Minerva Neurosciences team is committed to delivering long-term value to investors through solid business planning and execution. Our mission is to develop novel therapies that significantly improve the lives of patients by treating areas of high unmet need. We invite you to tour our web site and learn more about our products designed to treat schizophrenia, insomnia, major depressive disorder and Parkinson’s disease. Visit the Investors and Media portal.